positive regulation of lymphocyte proliferation
|
GO_0050671 |
[Any process that activates or increases the rate or extent of lymphocyte proliferation.] |
positive regulation of natural killer cell activation
|
GO_0032816 |
[Any process that activates or increases the frequency, rate or extent of natural killer cell activation.] |
positive regulation of epinephrine secretion
|
GO_0032812 |
[Any process that activates or increases the frequency, rate or extent of the regulated release of epinephrine.] |
positive regulation of secretion
|
GO_0051047 |
[Any process that activates or increases the frequency, rate or extent of the controlled release of a substance from a cell or a tissue.] |
regulation of epinephrine secretion
|
GO_0014060 |
[Any process that modulates the frequency, rate or extent of the regulated release of epinephrine.] |
negative regulation of epinephrine secretion
|
GO_0032811 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.] |
negative regulation of secretion
|
GO_0051048 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a substance from a cell or a tissue.] |
regulation of lymphocyte activation
|
GO_0051249 |
[Any process that modulates the frequency, rate or extent of lymphocyte activation.] |
positive regulation of lymphocyte activation
|
GO_0051251 |
[Any process that activates or increases the frequency, rate or extent of lymphocyte activation.] |
negative regulation of lymphocyte activation
|
GO_0051250 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of lymphocyte activation.] |
lacrimal gland development
|
GO_0032808 |
[The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.] |
gland development
|
GO_0048732 |
[The process whose specific outcome is the progression of a gland over time, from its formation to the mature structure. A gland is an organ specialised for secretion.] |
anatomical structure development
|
GO_0048856 |
[The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.] |
isoprenoid binding
|
GO_0019840 |
[Binding to an isoprenoid compound, isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues.] |
lipid binding
|
GO_0008289 |
[Binding to a lipid.] |
transporter activity
|
GO_0005215 |
[Enables the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, accross or in between cells.] |
molecular_function
|
GO_0003674 |
[A molecular process that can be carried out by the action of a single macromolecular machine, usually via direct physical interactions with other molecular entities. Function in this sense denotes an action, or activity, that a gene product (or a complex) performs.] |
dendrite cytoplasm
|
GO_0032839 |
[All of the contents of a dendrite, excluding the surrounding plasma membrane.] |
neuron projection cytoplasm
|
GO_0120111 |
[All of the contents of a plasma membrane bounded neuron projection, excluding the plasma membrane surrounding the projection.] |
cytoplasm
|
GO_0005737 |
[The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.] |